UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 561

Sortiert nach

Cost of Disease Progression in Diffuse Large B-Cell Lymphoma After Frontline Treatment With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

Clinical lymphoma, myeloma and leukemia, 2023-11, Vol.23 (11), p.e393-e404

2023

Link zum Volltext

Verfügbarkeit prüfen

Iqvia - Policy Analysis Project - Health Economic Evaluation of Genetic Testing: How Is the Link Between Genetic Testing and Patient Quality of Life Captured in Cost-Effectiveness Analyses?

de Pinho, Carolina Mota Alves Braga

2022

Link zum Volltext
ProQuest

U.S. Medicines Spending Grew in 2023 as Greater Access Offset COVID-19-related Decline, Says IQVIA Institute

Business Wire, 2024

2024

Link zum Volltext

Verfügbarkeit prüfen

Global Medicine Spending to Reach $2.3 Trillion by 2028 as More Patients Get Access to Better Therapies, Says IQVIA Institute Report

Business Wire, 2024

2024

Link zum Volltext

Verfügbarkeit prüfen

Global Oncology RD Activity Remains High and More Patients Have Been Treated for Cancer, says IQVIA Institute for Human Data Science

Business Wire, 2023

2023

Link zum Volltext

Verfügbarkeit prüfen

Use of Medicines in the U.S. Continued to Grow in 2022 while Patient Out-of-Pocket Costs Remain Low, Says IQVIA Institute

Business Wire, 2023

2023

Link zum Volltext

Verfügbarkeit prüfen

Global Oncology RD Surges While Cancer Care Disruptions Ease, Says IQVIA Institute for Human Data Science

Business Wire, 2022

2022

Link zum Volltext

Verfügbarkeit prüfen

Pharma RD Pipeline and New Product Launches Reach Record Levels in 2021 According to New IQVIA Institute for Human Data Science Report

Business Wire, 2022

2022

Link zum Volltext

Verfügbarkeit prüfen

Global Medicine Spending to Reach $1.8 Trillion in 2026, Including Spending on COVID-19 Vaccines, According to Study by the IQVIA Institute for Human Data Science

Business Wire, 2021

2021

Link zum Volltext

Verfügbarkeit prüfen

Global Oncology Innovation Continues Despite Pandemic; Global RD Pipeline Reached 3,500 New Drugs in 2020, up 75% from 2015, Says New Report from the IQVIA Institute for Human Data Science

Business Wire, 2021

2021

Link zum Volltext

Verfügbarkeit prüfen

Pharma RD Activity Surges Even Without COVID-19, Says Report from the IQVIA Institute for Human Data Science

Business Wire, 2021

2021

Link zum Volltext

Verfügbarkeit prüfen

Global Medicine Spending to Reach $1.6 Trillion in 2025 Excluding Spending on COVID-19 Vaccines, According to IQVIA Institute for Human Data Science Study

Business Wire, 2021

2021

Link zum Volltext

Verfügbarkeit prüfen

Q2 Solutions, an IQVIA and Quest Diagnostics Joint Venture, Improves Oncology’s Standard of Care with Genomics Technology Collaboration

Business Wire, 2020

2020

Link zum Volltext

Verfügbarkeit prüfen

Belong.Life Raises $14 Million Series B Round to Accelerate Growth of Global Oncology Solution and Expand Rollout End-to-end Patient Engagement and Health Research Platform: Series B Funding Round Led by IQVIA will Expand World's Largest Cancer Social Network and Advance Belong's Patient Engagement Platform for Payers, Providers and Life Science Companies

PR Newswire, 2019

2019

Link zum Volltext

Verfügbarkeit prüfen

IQVIA Real World Capabilities and Expertise Support Path to Label Expansion

Business Wire, 2019

2019

Link zum Volltext

Verfügbarkeit prüfen

IQVIA™ Institute for Human Data Science Releases Global Oncology Trends 2019 Study: Record Number of Cancer Drugs Launched in 2018 across 17 Indications

Business Wire, 2019

2019

Link zum Volltext

Verfügbarkeit prüfen

Contract Research Organization Services Market to Witness Huge Growth by 2025 | Key Players: Charles RiveI, Envigo, IQVIA, ICON PLC, LabCrop

M2 Presswire, 2018

2018

Link zum Volltext

Verfügbarkeit prüfen

The cost of cancer in Europe 2018

European journal of cancer (1990), 2020-04, Vol.129, p.41-49

2020

Link zum Volltext

Verfügbarkeit prüfen

Low blood levels of high-density lipoprotein (HDL) cholesterol are positively associated with cancer

Journal of cancer research and clinical oncology, 2022-11, Vol.148 (11), p.3039-3046

2022

Link zum Volltext

Verfügbarkeit prüfen

Real-World Efficacy and Tolerability of Brigatinib in Patients with Non-Small Cell Lung Cancer with Prior ALK-TKIs in the United States

The oncologist (Dayton, Ohio), 2022-09, Vol.27 (9), p.790-798

2022

Link zum Volltext

Verfügbarkeit prüfen

Are sleep disorders associated with the risk of gastrointestinal cancer?—A case–control study

Journal of cancer research and clinical oncology, 2023-10, Vol.149 (13), p.11369-11378

2023

Link zum Volltext

Verfügbarkeit prüfen

Incidence of other cancer diagnoses in women with breast cancer: a retrospective cohort study with 42,248 women

Breast cancer research and treatment, 2022-08, Vol.195 (1), p.75-82

2022

Link zum Volltext

Verfügbarkeit prüfen

Psychiatric disorder and its association with gastrointestinal cancer: a retrospective cohort study with 45,842 patients in Germany

Journal of cancer research and clinical oncology, 2023-11, Vol.149 (16), p.14509-14518

2023

Link zum Volltext

Verfügbarkeit prüfen

Pitfalls of Physician-Directed Treatment of Helicobacter pylori: Results from Two Phase 3 Clinical Trials and Real-World Prescribing Data

Digestive diseases and sciences, 2022-09, Vol.67 (9), p.4382-4386

2022

Link zum Volltext

Verfügbarkeit prüfen

Real-world drug utilization and treatment patterns in patients with tenosynovial giant cell tumors in the USA

Future oncology (London, England), 2024-02

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 561

Suche als RSS-Feed

Aktive Filter

PublikationsformReferenzeintrag

ThemaHumans

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(370)
Mit Volltextzugriff
(368)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancers
(63)
The Oncologist
(17)
The Lancet Oncology
(14)
Frontiers In Oncology
(12)
Advances In Therapy
(11)
Future Oncology
(11)
Journal Of Cancer Research And Clinical Oncology
(11)
Applied Clinical Trials
(9)
Cancer Science
(9)
Liver Cancer
(9)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(19)
... seit 30 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Cost of Disease Progression in Diffuse Large B-Cell Lymphoma After Frontline Treatment With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

Iqvia - Policy Analysis Project - Health Economic Evaluation of Genetic Testing: How Is the Link Between Genetic Testing and Patient Quality of Life Captured in Cost-Effectiveness Analyses?

U.S. Medicines Spending Grew in 2023 as Greater Access Offset COVID-19-related Decline, Says IQVIA Institute

Global Medicine Spending to Reach $2.3 Trillion by 2028 as More Patients Get Access to Better Therapies, Says IQVIA Institute Report

Global Oncology RD Activity Remains High and More Patients Have Been Treated for Cancer, says IQVIA Institute for Human Data Science

Use of Medicines in the U.S. Continued to Grow in 2022 while Patient Out-of-Pocket Costs Remain Low, Says IQVIA Institute

Global Oncology RD Surges While Cancer Care Disruptions Ease, Says IQVIA Institute for Human Data Science

Pharma RD Pipeline and New Product Launches Reach Record Levels in 2021 According to New IQVIA Institute for Human Data Science Report

Global Medicine Spending to Reach $1.8 Trillion in 2026, Including Spending on COVID-19 Vaccines, According to Study by the IQVIA Institute for Human Data Science

Global Oncology Innovation Continues Despite Pandemic; Global RD Pipeline Reached 3,500 New Drugs in 2020, up 75% from 2015, Says New Report from the IQVIA Institute for Human Data Science

Pharma RD Activity Surges Even Without COVID-19, Says Report from the IQVIA Institute for Human Data Science

Global Medicine Spending to Reach $1.6 Trillion in 2025 Excluding Spending on COVID-19 Vaccines, According to IQVIA Institute for Human Data Science Study

Q2 Solutions, an IQVIA and Quest Diagnostics Joint Venture, Improves Oncology’s Standard of Care with Genomics Technology Collaboration

IQVIA Real World Capabilities and Expertise Support Path to Label Expansion

IQVIA™ Institute for Human Data Science Releases Global Oncology Trends 2019 Study: Record Number of Cancer Drugs Launched in 2018 across 17 Indications

Contract Research Organization Services Market to Witness Huge Growth by 2025 | Key Players: Charles RiveI, Envigo, IQVIA, ICON PLC, LabCrop

The cost of cancer in Europe 2018

Low blood levels of high-density lipoprotein (HDL) cholesterol are positively associated with cancer

Real-World Efficacy and Tolerability of Brigatinib in Patients with Non-Small Cell Lung Cancer with Prior ALK-TKIs in the United States

Are sleep disorders associated with the risk of gastrointestinal cancer?—A case–control study

Incidence of other cancer diagnoses in women with breast cancer: a retrospective cohort study with 42,248 women

Psychiatric disorder and its association with gastrointestinal cancer: a retrospective cohort study with 45,842 patients in Germany

Pitfalls of Physician-Directed Treatment of Helicobacter pylori: Results from Two Phase 3 Clinical Trials and Real-World Prescribing Data

Real-world drug utilization and treatment patterns in patients with tenosynovial giant cell tumors in the USA

Aktive Filter

Suchergebnisse filtern